Citation Impact
Citing Papers
Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
2008 StandoutScience
Degradation of Fibrillar Collagen in a Human Melanoma Xenograft Improves the Efficacy of an Oncolytic Herpes Simplex Virus Vector
2006 StandoutNobel
Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
2007 StandoutScience
Dendritic Cell Targeting of Survivin Protein in a Xenogeneic Form Elicits Strong CD4+ T Cell Immunity to Mouse Survivin
2006 StandoutNobel
Progress and challenges towards targeted delivery of cancer therapeutics
2018 Standout
Advances in immunotherapy for melanoma
2016
Cell-Type-Specific Responses to Interleukin-1 Control Microbial Invasion and Tumor-Elicited Inflammation in Colorectal Cancer
2019
Cytokines and Vascular Permeability: An In Vitro Study on Human Endothelial Cells in Relation to Tumor Necrosis Factor-α-Primed Peripheral Blood Mononuclear Cells
2006
Purine nucleoside phosphorylases: properties, functions, and clinical aspects
2000
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Purine nucleoside phosphorylase from Cellulomonas sp.: physicochemical properties and binding of substrates determined by ligand-dependent enhancement of enzyme intrinsic fluorescence, and by protective effects of ligands on thermal inactivation of the enzyme
2002
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
MYC on the Path to Cancer
2012 Standout
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
2003 Standout
Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial
2017
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
2019 Standout
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Crystal Structure of Calf Spleen Purine Nucleoside Phosphorylase with Two Full Trimers in the Asymmetric Unit: Important Implications for the Mechanism of Catalysis
2004 StandoutNobel
Tumor necrosis factor, cancer and anticancer therapy
2004
Principles of nanoparticle design for overcoming biological barriers to drug delivery
2015 Standout
Gold nanostructures: a class of multifunctional materials for biomedical applications
2010
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
Malignant astrocytic glioma: genetics, biology, and paths to treatment
2007 Standout
Delivery materials for siRNA therapeutics
2013 Standout
Calf spleen purine nucleoside phosphorylase: structure of its ternary complex with an N(7)-acycloguanosine inhibitor and a phosphate anion
2001
Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment
2006
Oncolytic viruses
2002
Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity
2009 Standout
The Continuum of Cancer Immunosurveillance: Prognostic, Predictive, and Mechanistic Signatures
2013
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
The immunologic constant of rejection
2008
DNA methylation at promoter regions of interleukin 1B, interleukin 6, and interleukin 8 in non-small cell lung cancer
2012
Replication-selective oncolytic viruses in the treatment of cancer
2004
Nuclear factor-κB in cancer development and progression
2006 StandoutNature
Crystal structure of the purine nucleoside phosphorylase (PNP) from Cellulomonas sp. and its implication for the mechanism of trimeric PNPs
1999
Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer
2017 StandoutNobel
Novel cancer immunotherapy agents with survival benefit: recent successes and next steps
2011 StandoutNobel
Monitoring gene therapy with reporter gene imaging
2001
Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface
2013 Standout
Expression of activation-induced cytidine deaminase in human hepatocytes via NF-κB signaling
2007 StandoutNobel
STATs in cancer inflammation and immunity: a leading role for STAT3
2009 Standout
TGFβ in Cancer
2008 Standout
Enhancement of vaccinia vaccine potency by linkage of tumor antigen gene to gene encoding calreticulin
2004
Bioactive jatrophane diterpenes from Euphorbia guyoniana
2009
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
2013 Standout
The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1β
2006
Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
2018
Cancer-related inflammation
2008 StandoutNature
Gold nanoparticles in biomedical applications: recent advances and perspectives
2011 Standout
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Calreticulin exposure dictates the immunogenicity of cancer cell death
2006 Standout
The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions
2006
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
2006 Standout
Dengue
2007 Standout
NF-κB: linking inflammation and immunity to cancer development and progression
2005 Standout
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates
2011 StandoutNobel
Dose-dependent cross-talk between the transforming growth factor-β and interleukin-1 signaling pathways
2007
Potentiation of Simian Immunodeficiency Virus (SIV)-Specific CD4+ and CD8+ T Cell Responses by a DNA-SIV and NYVAC-SIV Prime/Boost Regimen
2001
A global approach to tumor immunology.
2004
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
The development of anticancer ruthenium(ii ) complexes: from single molecule compounds to nanomaterials
2017 Standout
Interleukin-1β–Driven Inflammation Promotes the Development and Invasiveness of Chemical Carcinogen–Induced Tumors
2007
β-Arrestins and Cell Signaling
2007 StandoutNobel
Hypoxia-Inducible Factor 1 and Dysregulated c-Myc Cooperatively Induce Vascular Endothelial Growth Factor and Metabolic Switches Hexokinase 2 and Pyruvate Dehydrogenase Kinase 1
2007 StandoutNobel
Gold Nanoparticles in Chemical and Biological Sensing
2012 Standout
25th Anniversary Article: Galvanic Replacement: A Simple and Versatile Route to Hollow Nanostructures with Tunable and Well‐Controlled Properties
2013 Standout
Monofunctionalized Gold Nanoparticles Stabilized by a Single Dendrimer Form Dumbbell Structures upon Homocoupling
2012 StandoutNobel
Immunogenicity and Antitumor Effects of Vaccination with Peptide Vaccine +/− Granulocyte-Monocyte Colony-Stimulating Factor and/or IFN-α2b in Advanced Metastatic Melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696
2009
Viral Vectors for Gene Therapy: Translational and Clinical Outlook
2015
Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine
2010
Toll-like receptor 3 signaling converts tumor-supporting myeloid cells to tumoricidal effectors
2012
Synergy of vaccine strategies to amplify antigen-specific immune responses and antitumor effects.
2001
Targeted gene knock-in by homology-directed genome editing using Cas9 ribonucleoprotein and AAV donor delivery
2017 StandoutNobel
Euphorbia Diterpenes: Isolation, Structure, Biological Activity, and Synthesis (2008–2012)
2014 Standout
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Atomically Precise Clusters of Noble Metals: Emerging Link between Atoms and Nanoparticles
2017 Standout
Works of Markus Puhlmann being referenced
Direct evidence for rapid and selective induction of tumor neovascular permeability by tumor necrosis factor and a novel derivative, colloidal gold bound tumor necrosis factor
2007
Vaccinia as a vector for tumor-directed gene therapy: Biodistribution of a thymidine kinase-deleted mutant
2000
Regional Versus Systemic Delivery of Recombinant Vaccinia Virus as Suicide Gene Therapy for Murine Liver Metastases
1999
Tumor-Specific Gene Delivery Using Recombinant Vaccinia Virus in a Rabbit Model of Liver Metastases
1999
Gene-expression profiling of the response of peripheral blood mononuclear cells and melanoma metastases to systemic IL-2 administration
2002
Thymidine Kinase-Deleted Vaccinia Virus Expressing Purine Nucleoside Phosphorylase as a Vector for Tumor-Directed Gene Therapy
1999
Complex interactions between the replicating oncolytic effect and the enzyme/prodrug effect of vaccinia-mediated tumor regression
2000
AMG 386 in combination with sorafenib in patients with metastatic clear cell carcinoma of the kidney
2012
Induction of permeability across endothelial cell monolayers by tumor necrosis factor (TNF) occurs via a tissue factor–dependent mechanism: relationship between the procoagulant and permeability effects of TNF
2002
A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver.
2000
Sensitization of tumor necrosis factor alpha-resistant human melanoma by tumor-specific in vivo transfer of the gene encoding endothelial monocyte-activating polypeptide II using recombinant vaccinia virus.
1999
The role of interleukin 1 in growth and metastasis of human cancer xenografts.
2006
Effect of interleukin 1 receptor antagonist gene transduction on human melanoma xenografts in nude mice.
2003
Planned survival analysis from KEYNOTE-045: Phase 3, open-label study of pembrolizumab (pembro) versus paclitaxel, docetaxel, or vinflunine in recurrent, advanced urothelial cancer (UC).
2017
Systemic administration of a recombinant vaccinia virus expressing the cytosine deaminase gene and subsequent treatment with 5-fluorocytosine leads to tumor-specific gene expression and prolongation of survival in mice.
1999